In the current study, ZBPYR significantly improved the chronic activation of the HPA axis, reduced blood glucose concentrations, promoted insulin sensitivity, slowed the progression of diabetes, as well as enhanced exploratory behavior, learning, and memory performance in PSD rats. The gene discussed is INS; the disease is diabetes mellitus.